Literature DB >> 6455215

Cardiac hypertrophy in idiopathic dilated congestive cardiomyopathy: a clinicopathologic study.

I J Benjamin, E H Schuster, B H Bulkley.   

Abstract

Although clinical studies indicate that patients with idiopathic dilated congestive cardiomyopathy who develop electrocardiographic or angiographic signs of left ventricular (LV) hypertrophy may survive longer, there is little morphologic evidence for such anatomic favorable of unfavorable prognostic groups. We studied 30 autopsied patients who died of dilated cardiomyopathy; of these, 15 died within 1 year of the first symptom of their disease (short-term survivors) and 15 patients died 1-14 years after initial symptoms (long-term survivors). There were no significant differences in sex, race, clinical presentation or cause of death between the groups, but there were significant morphologic differences. In the short-term survivors, average heart weight was 540 g and LV wall thickness was 1.0 cm, whereas in the long-term survivors, the average heart weight was 759 g and LV wall thickness was 1.3 cm (p less than 0.001). LV cavity dilatation as measured by maximal transverse diameter from the postmortem angiograms did not differ between the two groups. These patients were compared with 10 autopsied patients with normal hearts and no clinical cardiac disease and 10 autopsied patients with volume overload secondary to valvular regurgitation. An LV hypertrophy/dilatation index (thickness/diameter) was 0.17 +/- 0.07 for the short-term survivors, 0.21 +/- 0.07 for the long-term survivors, 0.38 +/- 0.07 for volume overload patients, and 0.48 +/- 0.19 for normal subjects (F = 20.24, p less than 0.001). Thus, in patients with hypertrophy due to volume overload, wall thickening increased with dilatation, returning the ratio of wall thickness to cavity size toward normal. In contrast, among the idiopathic congestive cardiomyopathies, dilatation was disproportionate to hypertrophy and the difference was most marked for short-term survivors.

Entities:  

Mesh:

Year:  1981        PMID: 6455215     DOI: 10.1161/01.cir.64.3.442

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

1.  Deficiency of bone morphogenetic protein-3b induces metabolic syndrome and increases adipogenesis.

Authors:  Íngrid Martí-Pàmies; Robrecht Thoonen; Patrick Seale; Alexia Vite; Alex Caplan; Jesus Tamez; Lauren Graves; Wei Han; Emmanuel S Buys; Donald B Bloch; Marielle Scherrer-Crosbie
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-06-30       Impact factor: 4.310

2.  Factors discriminating survivors and nonsurvivors in alcoholic heart disease.

Authors:  M Kino; Y Nakayama; M Hara; S Yamamoto; K Sawada; T Saitoh; M Suwa; Y Hirota; Y Kitaura; K Kawamura
Journal:  Heart Vessels Suppl       Date:  1985

3.  Prognosis and treatment of cardiomyopathy and myocarditis.

Authors:  J B O'Connell; M R Costanzo-Nordin; R S Engelmeier; D E Wallis; J A Robinson; P J Scanlon
Journal:  Heart Vessels Suppl       Date:  1985

4.  An immigrant's experience: science is a discipline without borders.

Authors:  Ivor J Benjamin
Journal:  J Clin Invest       Date:  2021-05-03       Impact factor: 14.808

5.  Fabry Disease With Concomitant Lewy Body Disease.

Authors:  Kelly Del Tredici; Albert C Ludolph; Simone Feldengut; Christian Jacob; Heinz Reichmann; Jürgen R Bohl; Heiko Braak
Journal:  J Neuropathol Exp Neurol       Date:  2020-04-01       Impact factor: 3.685

6.  Rho-kinase pathway activation and apoptosis in circulating leucocytes in patients with heart failure with reduced ejection fraction.

Authors:  Maria Paz Ocaranza; Jackeline Moya; Jorge E Jalil; Sergio Lavandero; Alexis M Kalergis; Cristián Molina; Luigi Gabrielli; Iván Godoy; Samuel Córdova; Pablo Castro; Paul Mac Nab; Victor Rossel; Lorena García; Javier González; Cristián Mancilla; Camila Fierro; Luis Farías
Journal:  J Cell Mol Med       Date:  2019-11-28       Impact factor: 5.310

7.  Identification of Potential Gene Interactions in Heart Failure Caused by Idiopathic Dilated Cardiomyopathy.

Authors:  Huijuan Huang; Beibei Luo; Boqun Wang; Qianwen Wu; Yuming Liang; Yan He
Journal:  Med Sci Monit       Date:  2018-10-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.